<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="retraction" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">OR</journal-id>
<journal-title-group>
<journal-title>Oncology Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1021-335X</issn>
<issn pub-type="epub">1791-2431</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/or.2024.8795</article-id>
<article-id pub-id-type="publisher-id">OR-52-4-08795</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>[Retracted] MicroRNA‑642a‑5p inhibits colon cancer cell migration and invasion by targeting collagen type I &#x03B1;1</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Xiaoguang</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Song</surname><given-names>Zhengwei</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Hu</surname><given-names>Biwen</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Chen</surname><given-names>Zhenwei</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Chen</surname><given-names>Fei</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Cao</surname><given-names>Chenxi</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection">
<month>10</month>
<year>2024</year></pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>08</month>
<year>2024</year></pub-date>
<volume>52</volume>
<issue>4</issue>
<elocation-id>136</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2024 Wang et al.</copyright-statement>
<copyright-year>2024</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Rep 45: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retracted-article" vol="45" page="933" id="RA1" xlink:href="10.3892/or.2020.7905" ext-link-type="doi">933&#x2013;944</related-article>, 2021; DOI: 10.3892/or.2020.7905</p>
<p>Following the publication of this paper, it was drawn to the Editor&#x0027;s attention by a concerned reader that certain of the cell invasion assay data shown in Fig. 6B on p. 940, and western blot data featured in Fig. 7B on p. 942, had already appeared in previously published articles written by different authors at different research institutes. Owing to the fact that the contentious data in the above article had already been published prior to its submission to <italic>Oncology Reports</italic>, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a satisfactory reply. The Editor apologizes to the readership for any inconvenience caused.</p>
</body>
</article>
